EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Does Phage Therapy Need a Pan-Phage?

Petros Bozidis iD, Eleftheria Markou, Athanasia Gouni, Konstantina Gartzonika

Pathogens · 2024

DOI: 10.3390/pathogens13060522 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, 2024. Verfasst von Petros Bozidis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece. Hauptthemen laut MEDLINE: Bacteria, Bacterial Infections, Bacteriophages, Host Specificity. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of multidrug-resistant bacteria is undoubtedly one of the most serious global health threats. One response to this threat that has been gaining momentum over the past decade is ‘phage therapy’. According to this, lytic bacteriophages are used for the treatment of bacterial infections, either alone or in combination with antimicrobial agents. However, to ensure the efficacy and broad applicability of phage therapy, several challenges must be overcome. These challenges encompass the development of methods and strategies for the host range manipulation and bypass of the resistance mechanisms developed by pathogenic bacteria, as has been the case since the advent of antibiotics. As our knowledge and understanding of the interactions between phages and their hosts evolves, the key issue is to define the host range for each application. In this article, we discuss the factors that affect host range and how this determines the classification of phages into different categories of action. For each host range group, recent representative examples are provided, together with suggestions on how the different groups can be used to combat certain types of bacterial infections. The available methodologies for host range expansion, either through sequential adaptation to a new pathogen or through genetic engineering techniques, are also reviewed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteriaBacterial InfectionsBacteriophagesHost SpecificityPhage TherapyHumansAnti-Bacterial AgentsDrug Resistance, Multiple, Bacterial

Stichwörter der Autor:innen

bacteriophagebroad host rangehost rangemonovalent phagenarrow host rangephage therapypolyvalent phage

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Microbiology, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.
  • Department of Microbiology, University Hospital of Ioannina, 45500 Ioannina, Greece.

ORCID-Profile: Petros Bozidis

Zitieren

APA

Bozidis, P., Markou, E., Gouni, A., & Gartzonika, K. (2024). Does Phage Therapy Need a Pan-Phage?. Pathogens. https://doi.org/10.3390/pathogens13060522

Vancouver

Bozidis P, Markou E, Gouni A, Gartzonika K. Does Phage Therapy Need a Pan-Phage?. Pathogens. 2024. doi:10.3390/pathogens13060522

BibTeX
@article{Bozidis2024,
  author = {Bozidis, Petros and Markou, Eleftheria and Gouni, Athanasia and Gartzonika, Konstantina},
  title = {Does Phage Therapy Need a Pan-Phage?},
  journal = {Pathogens},
  year = {2024},
  doi = {10.3390/pathogens13060522}
}
Kostenlos starten →